Literature DB >> 24319250

Heparin-induced thrombocytopenia.

Grace M Lee1, Gowthami M Arepally.   

Abstract

Heparin-induced thrombocytopenia (HIT) is a prothrombotic disorder caused by antibodies that recognize complexes of platelet factor 4 (PF4) and heparin. HIT is frequently considered in the differential diagnosis of thrombocytopenia occurring in patients on heparin therapy. HIT is a challenging diagnosis because of routine heparin use in hospitalized patients, the common occurrence of thrombocytopenia, and high rates of anti-PF4/heparin seroconversions in patients treated with heparin. Our diagnostic approach to HIT is presented here, underscoring critical elements of clinical and laboratory evaluation.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24319250      PMCID: PMC4153428          DOI: 10.1182/asheducation-2013.1.668

Source DB:  PubMed          Journal:  Hematology Am Soc Hematol Educ Program        ISSN: 1520-4383


  44 in total

1.  Temporal aspects of heparin-induced thrombocytopenia.

Authors:  T E Warkentin; J G Kelton
Journal:  N Engl J Med       Date:  2001-04-26       Impact factor: 91.245

2.  Is the incidence of heparin-induced thrombocytopenia affected by the increased use of heparin for VTE prophylaxis?

Authors:  Amy Zhou; Anne Winkler; Amir Emamifar; Bryce Gartland; Alexander Duncan; Ana Antun; Martha Arellano; G Allen Tindol; Jerrold H Levy; William A Bornstein; Ira R Horowitz; Hanna Jean Khoury
Journal:  Chest       Date:  2012-11       Impact factor: 9.410

3.  Laboratory testing for heparin-induced thrombocytopenia: a conceptual framework and implications for diagnosis.

Authors:  T E Warkentin; A Greinacher; Y Gruel; R H Aster; B H Chong
Journal:  J Thromb Haemost       Date:  2011-12       Impact factor: 5.824

Review 4.  Nonheparin anticoagulants for heparin-induced thrombocytopenia.

Authors:  John G Kelton; Donald M Arnold; Shannon M Bates
Journal:  N Engl J Med       Date:  2013-02-21       Impact factor: 91.245

5.  Incidence of thrombocytopenia among patients receiving heparin venous thromboembolism prophylaxis.

Authors:  Tracy Y Wang; Emily F Honeycutt; Victor F Tapson; Stephan Moll; Christopher B Granger; E Magnus Ohman
Journal:  Am J Med       Date:  2012-08-30       Impact factor: 4.965

Review 6.  Predictive value of the 4Ts scoring system for heparin-induced thrombocytopenia: a systematic review and meta-analysis.

Authors:  Adam Cuker; Phyllis A Gimotty; Mark A Crowther; Theodore E Warkentin
Journal:  Blood       Date:  2012-09-18       Impact factor: 22.113

7.  Delayed-onset heparin-induced thrombocytopenia and thrombosis.

Authors:  T E Warkentin; J G Kelton
Journal:  Ann Intern Med       Date:  2001-10-02       Impact factor: 25.391

8.  Novel diagnostic assays for heparin-induced thrombocytopenia.

Authors:  Adam Cuker; Ann H Rux; Jillian L Hinds; May Dela Cruz; Serge V Yarovoi; Isola A M Brown; Wei Yang; Barbara A Konkle; Gowthami M Arepally; Stephen P Watson; Douglas B Cines; Bruce S Sachais
Journal:  Blood       Date:  2013-02-27       Impact factor: 22.113

9.  FcγRIIa proteolysis as a diagnostic biomarker for heparin-induced thrombocytopenia.

Authors:  I Nazi; D M Arnold; J W Smith; P Horsewood; J C Moore; T E Warkentin; M A Crowther; J G Kelton
Journal:  J Thromb Haemost       Date:  2013-06       Impact factor: 5.824

Review 10.  Heparin-induced thrombocytopenia and cardiac surgery.

Authors:  Theodore E Warkentin; Andreas Greinacher
Journal:  Ann Thorac Surg       Date:  2003-08       Impact factor: 4.330

View more
  23 in total

1.  IVIg for Treatment of Severe Refractory Heparin-Induced Thrombocytopenia.

Authors:  Anand Padmanabhan; Curtis G Jones; Shannon M Pechauer; Brian R Curtis; Daniel W Bougie; Mehraboon S Irani; Barbara J Bryant; Jack B Alperin; Thomas G Deloughery; Kevin P Mulvey; Binod Dhakal; Renren Wen; Demin Wang; Richard H Aster
Journal:  Chest       Date:  2017-04-17       Impact factor: 9.410

2.  Progressive thrombocytopenia after cardiac surgery in a 67-year-old man.

Authors:  Ilana Kopolovic; Theodore E Warkentin
Journal:  CMAJ       Date:  2014-04-22       Impact factor: 8.262

3.  Bilateral adrenal haemorrhage associated with heparin-induced thrombocytopaenia during treatment of Fournier gangrene.

Authors:  Timothy Lee Tattersall; Isaac A Thangasamy; Jamie Reynolds
Journal:  BMJ Case Rep       Date:  2014-10-14

Review 4.  Recent advances in biotechnology for heparin and heparan sulfate analysis.

Authors:  Meng Qiao; Lei Lin; Ke Xia; Jun Li; Xing Zhang; Robert J Linhardt
Journal:  Talanta       Date:  2020-06-14       Impact factor: 6.057

5.  Development of bioanalytical assays for variegin, a peptide-based bivalent direct thrombin inhibitor.

Authors:  Norrapat Shih; Leonardo Pinto de Carvalho; Yie Hou Lee; Mauricio Macario Rocha; Adriano Henrique Pereira Barbosa; José Marconi A de Sousa; Antonio Carlos de C Carvalho; R Manjunatha Kini; Mark Y Chan
Journal:  Bioanalysis       Date:  2017-05-10       Impact factor: 2.681

Review 6.  Advances in the pathophysiology and treatment of heparin-induced thrombocytopenia.

Authors:  Steven E McKenzie; Bruce S Sachais
Journal:  Curr Opin Hematol       Date:  2014-09       Impact factor: 3.284

7.  Atomic description of the immune complex involved in heparin-induced thrombocytopenia.

Authors:  Zheng Cai; Serge V Yarovoi; Zhiqiang Zhu; Lubica Rauova; Vincent Hayes; Tatiana Lebedeva; Qun Liu; Mortimer Poncz; Gowthami Arepally; Douglas B Cines; Mark I Greene
Journal:  Nat Commun       Date:  2015-09-22       Impact factor: 14.919

Review 8.  Update on argatroban for the prophylaxis and treatment of heparin-induced thrombocytopenia type II.

Authors:  Elisavet Grouzi
Journal:  J Blood Med       Date:  2014-08-13

9.  Safety and economic considerations of argatroban use in critically ill patients: a retrospective analysis.

Authors:  Se-Chan Kim; Nicole Tran; Jens-Christian Schewe; Olaf Boehm; Maria Wittmann; Ingo Graeff; Andreas Hoeft; Georg Baumgarten
Journal:  J Cardiothorac Surg       Date:  2015-02-07       Impact factor: 1.637

Review 10.  Prognostic factors for patients with heparin-induced thrombocytopenia: a systematic review.

Authors:  Giorgia Colarossi; Heike Schnöring; Andromahi Trivellas; Marcel Betsch; Nima Hatam; Jörg Eschweiler; Markus Tingart; Filippo Migliorini
Journal:  Int J Clin Pharm       Date:  2020-10-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.